Home » Newsletters » BioWorld Science

BioWorld Science

March 10, 2008

View Archived Issues

Experiments demonstrate alemtuzumab potential in ovarian cancer

AZD-0530 checks activity of MUC16+ ovarian cancer cells

Vermillion research identifies potential markers of ovarian cancer

PharmAthene reports results from initial pharmacokinetic studies of Protexia

Akela initiate phase I clinical trial of Edacs abuse deterrent opioid

IRD reports results from Senegalese study of the ELISPOT and TST tests for TB

Medarex reviews highlights of fourth quarter and full-year 2007

Recent patents divulge novel analgesic agents

New gene involved in ALS identified

Cortex receives German approval for two Ampakine CX-717 trials

Eden Biodesign and Stealthyx to develop enhanced treatment for rheumatoid arthritis

GammaCan presents update in VitiGam program for melanoma

Gilead submits MAA for aztreonam lysine 75 mg powder for nebulizer solution

Phase I NVC-422 trial commences in catheter-associated urinary tract infections

Singulex enters collaboration with Novartis Pharma for Erenna biomarker detection platform

Health Canada grants approval to Chemokine for phase II study of CTCE-9908 in liver cancer

ProMetic reports results from phase II trial of PBI-1402 in chemotherapy-induced anemia

Metabolon launches third-generation metabolomics platform for biochemical profiling

FDA approves Biocompatibles' phase II trial of Paragon Bead in hepatic colorectal metastases

New treatment options for cardiovascular disorders described in patent literature

Novel therapeutic agents for HIV infection disclosed in recent patents

Keryx reports negative results from SUN-MICRO phase III clinical trial of Sulonex

Genta enters worldwide licensing agreement with Daiichi Sankyo for taxane drug tesetaxel

FDA grants marketing approval to Spectrum for Levoleucovorin for injection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...